Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Smoking linked to hair loss in Asian men.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Early balding linked to higher heart disease risk.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Obese women with PCOS are more likely to have fatty liver disease.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Researchers made a special butter with added betasitosterol that could be healthier for the heart and stayed good for three months.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Acne is an important sign of androgen excess disorders in women.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

Birth control pills can help reduce mild to moderate acne in women.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

AGA patients have higher heart disease risk.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.